Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Short-term Investments: 2021-2023

Historic Short-term Investments for Immuneering (IMRX) over the last 3 years, with Dec 2023 value amounting to $26.3 million.

  • Immuneering's Short-term Investments fell 81.33% to $5.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $5.5 million, marking a year-over-year decrease of 81.33%. This contributed to the annual value of $26.3 million for FY2023, which is 20.15% down from last year.
  • Latest data reveals that Immuneering reported Short-term Investments of $26.3 million as of FY2023, which was down 20.15% from $32.9 million recorded in FY2022.
  • Over the past 5 years, Immuneering's Short-term Investments peaked at $74.3 million during FY2021, and registered a low of $26.3 million during FY2023.
  • In the last 3 years, Immuneering's Short-term Investments had a median value of $32.9 million in 2022 and averaged $44.5 million.
  • Data for Immuneering's Short-term Investments shows a maximum YoY crashed of 55.74% (in 2022) over the last 5 years.
  • Yearly analysis of 3 years shows Immuneering's Short-term Investments stood at $74.3 million in 2021, then crashed by 55.74% to $32.9 million in 2022, then decreased by 20.15% to $26.3 million in 2023.